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This study aimed at determining changes in plasma activities of some enzymes and concentrations of 
plasma organic constituents which are often used in the assessment of liver functions in uninfected 
rats (UNR) and Plasmodium berghei infected rats (INR), following a week of intramuscular 
administration of artemether (12.5 to 50.0 mg/kg/day). The observed changes were related to the effects 
of artemether on the liver of the rats. At all the doses tested, the plasma concentrations of total and 
conjugated bilirubin increased significantly in both INR and UNR. A significant decrease in the plasma 
concentrations of glucose was also observed in UNR. The levels of cholesterol were significantly higher 
in INR than UNR. Plasma glutamate oxaloacetate transaminase (GOT) activity was significantly 
increased in both categories of rats, but more significantly in INR. The activity of plasma glutamate 
pyruvate transaminase (GPT) increased significantly at 12.5 and 25.0 mg/kg only in UNR, while a 
significant increase was observed at 50.0 mg/kg in the INR. Photomicrograph of the liver revealed 
progressive tissue damage which was more pronounced in INR than UNR. We concluded that high 
doses of artemether are toxic to the liver of both infected and uninfected rats. 
  
Key words: Artemether, bilirubin, uric acid, plasma glutamate oxaloacetate transaminase, plasma glutamate 
pyruvate transaminase, Plasmodium berghei. 
 
 
INTRODUCTION 
 
Artemether is one of the antimalarial drugs derived from 
artemisinin. It is reputed for its efficacy in the treatment of  
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Abbreviations: UNR, Uninfected rats; INR, infected rats; GOT, 
glutamate oxaloacetate transaminase; GPT, glutamate pyruvate 
transaminase. 
malaria, including those resulting from infection by 
chloroquine – resistant strains of Plasmodium and this 
has been reported (Qinghaosu Antimalarial Coordinating 
Research Group, 1979a; 1979b; China Cooperative 
Research Group, 1982). As one of the first lines of 
treatment of cerebral malaria caused by chloroquine-
resistant Plasmodium, artemether is being used 
worldwide in combination with other anti-malarials (Van 
Vugt et al., 1999; Nosten et al., 2000). Administration of 
multiple  doses  of  the  drug  to  dogs,  rats   and   rhesus  
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monkeys by intramuscular route has been reported to 
produce neurotoxic effects such as gait disturbances, 
loss of spinal and pain reflexes (Petras et al., 1997; 
Sumalee et al., 1997; Nontprasert et al., 1998, 2000). 
High doses of artemether were also reported to have 
caused neuronal necrosis in the region of the brainstem 
of rats (Genovese et al., 1998). Anorexia and a dose-
dependent reduction in body weight have also been 
reported at these high doses (Qigui et al., 1998). 
Following one week of intramuscular administration of 
12.5 to 50.0 mg/kg of artemether, we have reported 
changes in some of the visceral functions of Wistar rats 
(Akomolafe et al., 2006). We reported a pattern of 
anorexia which manifested as a significant reduction in 
the food and water intake of all the treated rats. This was 
accompanied by significant increases in their urine 
output. These effects persisted until even one week after 
the stoppage of drug administration in those rats that 
received 50.0 mg/kg of the drug, whereas those that 
received lower doses had only their food intake restored 
during this period.  
We concluded that the significant increase in urine 
output without a corresponding increase in the water 
intake of the rats could exacerbate dehydration and lead 
to a deleterious effect on the ionic balance of the body 
fluid of the rats. We also postulated that high doses of 
artemether could cause impairment of renal function of 
the treated rats and that the significant increase in urine 
output could be due to other effects of the drug on thirst, 
anti-diuretic hormone output and the osmotic pressure of 
their blood (Akomolafe et al., 2006). Our recent study on 
the effects of seven days’ administration of the same 
doses of artemether on the plasma and urine levels of 
some major electrolytes of the body fluid in uninfected 
rats revealed that their concentrations in urine decreased 
dose dependently during treatment (Akomolafe et al., 
2011). The reduction was not reversed at 25 and 50 
mg/kg even one week after treatment. Dose-dependent 
tissue degeneration was observed in the kidneys of the 
rats. We concluded that the doses of artemether used in 
the study caused impairment of renal functions in 
apparently healthy rats, leading to the inability of the 
kidneys to concentrate urine. We have also repeated the 
same experiment with Plasmodium berghei infected rats 
(Akomolafe et al., 2012). 
The urine levels of sodium (Na
+
) and potassium (K
+
) 
decreased significantly during treatment. One week post-
treatment with 12.5 mg/kg of artemether, the urine 
concentrations of the electrolytes rose back to values that 
were not significantly different from pre-treatment. At 25 
and 50 mg/kg, their urine concentrations still remained 
significantly lower than pre-treatment levels. Plasma 
concentrations of the electrolytes one week post-
treatment increased, but they were only significant at 25 
mg/kg for K
+
. A significant increase in the plasma level of 
creatinine was observed at all doses of the drug one 
week  post-treatment.  Dose-dependent  degeneration  of  
 
 
 
 
the renal tissue of all the experimental rats was also 
observed. We concluded that high doses of artemether 
caused progressive degeneration of the renal tissue of P. 
berghei infected rats. Since literature is scanty on the 
influence of artemether on the liver function of both 
healthy and infected rats, this study was carried out to 
investigate if artemether provokes alterations in blood 
enzyme activities and organic compounds levels often 
used in the assessment of liver functions. 
 
 
MATERIALS AND METHODS 
 
Uninfected experimental rats  
 
Eighty (80) adult Wistar rats (200 to 250 g) were used for this study. 
The rats were obtained from the Animal Holding of the Department 
of Physiological Sciences, Obafemi Awolowo University, Ile-Ife, 
Nigeria. They were kept in the laboratory under natural light/dark 
cycle and were fed on normal mouse cubes (Ladokun Feeds, 
Ibadan, Nigeria) and clean water. The care and use of the animals 
and the experimental protocol of the study were in accordance with 
Experimental Animal Care and Use Regulation of the Animal 
House, College of Health Sciences, Obafemi Awolowo University, 
Ile Ife. They were divided into four groups labeled I, II, III and IV. 
Each of the groups consisted of 20 rats, 10 males and 10 females. 
Each of the rats was housed in a separate metabolic cage (Ohaus 
R Model; Ohaus, Pine Brook, NJ, USA) with access to food and 
water ad libitum. The rats were acclimatized for two weeks before 
the commencement of the experiments. 
 
 
Drug administration  
 
Injectable form of artemether (80 mg/mL) manufactured by 
Kunming Pharmaceutical Factory, Kunming, People’s Republic of 
China) was dispensed in 1 mL ampoules for intramuscular injection. 
 
 
Dose regimens  
 
Each rat in group I (uninfected control, UNFC) that weighed 250 g 
was given 0.16 mL normal saline (equivalent to the volume of the 
drug that was administered to each 250 g rat that received 50.0 
mg/kg/day of artemether) for one week. Each of the rats in groups 
II, III and IV received 12.5, 25.0 and 50.0 mg/kg/day of artemether, 
respectively, via the intramuscular route for one week. 
 
 
Infected experimental rats  
 
Another 80 adult Wistar rats (200 to 250 g) were used for this study. 
They were obtained from the same source, fed and housed as the 
uninfected rats. The rats were divided into four groups labeled I, II, 
III and IV like the uninfected rats. Each group consisted of 10 males 
and 10 female rats. 
 
 
Parasite used  
 
P. berghei (NK 65 strain) was used for this study. It was acquired 
from the Department of Pharmacology and Therapeutics, University 
of Ibadan, Nigeria.  
 
 
 
 
Inoculum preparation  
 
A donor rat infected with P. berghei with approximately 20 to 32% 
of parasitaemia was used. After determining total red blood cell 
(RBC) number, blood was obtained from the animal under 
chloroform anaesthesia by cardiac puncture and diluted in normal 
saline for a final inoculum of 3.0 x 10
7
 parasitized RBC (pRBC) in 
0.2 mL of blood (a modification of the method described by Xiao et 
al., 2002). 
 
 
Preparation of thin and thick films and staining technique  
 
Small drops of blood from the tails of the infected rats were 
collected on clean non-greasy slides for thin and thick blood films. 
The films were air-dried and the thin film only was further fixed with 
a few drops of methanol, and left again to air-dry. The slides (thin 
and thick films) were stained with Giemsa stain, diluted (1:2.5) in a 
sodium phosphate buffer pH 7.2 and left to stand for 10 to 12 min. 
After pouring off the stain, the slides were rinsed with the buffer 
solution and allowed to air-dry. 
 
 
Evaluation of parasitaemia  
 
Evaluation of parasitaemia; percentage parasitaemia was 
determined (total number of pRBC / total number of RBC * 100) in 
ten fields on each slide for each infected rat. Parasitaemias as high 
as 25% were achieved on post inoculation day 3 (PID3). The 
animals with parasitaemias at least equal to 25% were treated with 
artemether on post-infection day 5 (PID5). 
 
 
Drug administration 
 
This was carried out as for the uninfected rats. 
 
 
Dose regimens 
 
The same dose regimen described for the uninfected rats was 
adopted for the infected animals. The Group I rats of this study 
were the control (infected control INFC). On treatment day 14 
(TD14), that is one week after drug administration, the rats (both the 
Control and experimental) were sacrificed under chloroform 
anaesthesia. Blood was collected into a lithium heparinized 
specimen bottle by cardiac puncture, immediately centrifuged at 
3000 rpm for 20 min and sent to biochemical analysis. Otherwise, 
plasma samples were frozen at -4°C until further use. Plasma levels 
of liver transaminases and other organic constituents were 
measured with spectrophotometer (Model SP 310, Biosystems 
Limited, Spain). Levels of plasma glutamate oxaloacetate 
transaminase, plasma glutamate pyruvate transaminase, glucose, 
uric acid and cholesterol were determined by the use of appropriate 
biochemical kits purchased from Randox Laboratories, UK. Total 
bilirubin, and conjugated bilirubin were measured using the diazo 
method of Jendrassik and Grof (1938), creatinine by Jaffe’s 
reaction (Jaffe, 1886) and urea by diacetyl monoamine methods of 
Veniamin and Vakortzi-Lemonies (1970). The livers of the rats were 
taken out and kept in a 10% formalin solution until tissue sections 
were dyed with hematoxylin eosin staining for histological studies. 
Photomicrographs of the tissues were taken using Lect3 Dialux 
Microscope (Bright Field 400 x). 
 
 
Statistical analysis 
 
The results were expressed as mean ± standard error of mean 
(S.E.M) and subjected to one-way analysis of variance (ANOVA).  
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Significant differences were further tested by the Duncans Multiple 
Range and Student Neuman Keuls tests. Differences with 
probability values of p < 0.05 were considered significant. 
 
 
RESULTS 
 
Effects of artemether on plasma organic compounds  
 
Total bilirubin  
 
In the uninfected rats (UNR), there was a slight but 
significant increase in the plasma level of total bilirubin 
(Figure 1). In the INR, the increase in plasma total 
bilirubin was significantly higher than that of the UNR at 
any particular dose. In the INR, those rats that received 
normal saline had the least plasma level of total bilirubin. 
 
  
Conjugated bilirubin  
 
The pattern of artemether-induced increase in the plasma 
level of conjugated bilirubin in the INR was the same as 
that of total bilirubin, that is, it was significantly higher 
than the UNR at any particular dose (Figure 2).  
 
 
Cholesterol  
 
In the UNR, a significant increase in cholesterol level of 
the plasma was observed only in those rats that received 
50.0 mg/kg of artemether (Figure 3). Infected rats had a 
significantly higher cholesterol level at any of the doses of 
artemether used, including NS, than the UNR.  
 
 
Glucose  
 
The plasma glucose level of the UNR decreased 
significantly and dose dependently (Figure 4). The INR 
had lower plasma glucose levels than the UNR at 12.5 
and 25.0 mg/kg of artemether and even than the control 
rats that received NS (Figure 4). At 50.0 mg/kg the 
plasma glucose level of INR was significantly higher than 
that of the UNR.  
 
  
Urea  
 
In the UNR, the plasma level of urea was significantly 
reduced in rats that received 12.5 and 25.0 mg/kg of 
artemether (Figure 5). The plasma urea level was higher 
in the INR than in the UNR at 25 mg/kg.  
 
 
Uric acid  
 
Artemether caused a significant increase in the plasma 
level of uric acid in the UNR, the highest level occurring 
at 50.0 mg/kg of artemether (Figure 6). In the INR that 
received normal saline (control 2), the plasma uric acid 
level was significantly higher than that of the UNR. In  the  
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Figure 1. Effect of artemether on the total bilirubin concentration of the plasma of UNR and INR. Each bar is mean ± S.E.M. (n = 20). 
*Significant difference between INR and UNR. 
a
Significant difference between control and UNR. 
b
Significant difference between control 
and INR. 
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Figure 2. Effect of artemether on the conjugated bilirubin concentration of the plasma of UNR and INR. Each bar is mean ± S.E.M. 
(n = 20). *Significant difference between INR and UNR (p < 0.05). 
a
Significant difference between control and UNR (p < 0.05). 
b
Significant difference between control and INR (p < 0.05). 
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Figure 3. Effect of artemether on the cholesterol concentration of the plasma of UNR and INR. Each bar is mean ± 
S.E.M. (n = 20). *Significant difference between INR and UNR. 
a
Significant difference between control and UNR. 
b
Significant difference between control and INR. 
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Figure 4. Effect of artemether on the glucose concentration of the plasma of uninfected and P. berghei infected rats. Each bar 
is mean ± S.E.M. (n = 20). *Significant difference between INR and UNR. 
a
Significant difference between control and UNR. 
b
Significant difference between control and INR. 
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Figure 5. Effect of artemether on the urea concentration of the plasma of uninfected and P. berghei infected rats. 
Each bar is mean ± S.E.M. (n = 20). *Significant difference between INR and UNR. 
a
Significant difference between 
control and UNR. 
b
Significant difference between control and INR. 
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Figure 6. Effect of artemether on the uric acid concentration of the plasma of uninfected and P. berghei infected rats. 
Each bar is mean ± S.E.M. (n = 20). *Significant difference between INR and UNR. 
a
Significant difference between control 
and UNR. 
b
Significant difference between control and INR. 
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Figure 7. Effect of artemether on the creatinine concentration of the plasma of uninfected and P. berghei infected rats. Each 
bar is mean ± S.E.M. (n = 20). *Significant difference between INR and UNR. 
a
Significant difference between control and UNR. 
b
Significant difference between control and INR. 
 
 
 
INR that received 12.5 and 25.0 mg/kg of artemether, the 
plasma uric acid level was significantly lower than that of 
the UNR at the corresponding doses. At 50.0 mg/kg, the 
INR had a higher, though insignificant, plasma uric acid 
level than the UNR that got the same dose of artemether. 
 
  
Creatinine  
 
In the UNR, there was no significant change in the 
plasma creatinine level of the rats at all the doses tested 
(Figure 7). In the INR, the plasma creatinine levels of the 
treated rats were significantly higher than those of the 
control. INR that received NS had a significantly lower 
plasma creatinine level than the UNR that got the same 
fluid.  
 
 
Effect of artemether on liver transaminases  
 
Plasma glumatate oxaloacetate transaminase (GOT)  
 
Among the UNR, the plasma activity of GOT in the 
treated rats was not significantly different from that of the 
control rats (Figure 8). Among the INR, the levels of GOT 
were significantly higher than those of the UNR at any 
given dose, including UNFC. 
 
 
Plasma glumatate pyruvate transaminase (GPT)  
 
Among the UNR, GPT activity was significantly higher at 
12.5 and 25.0 mg/kg than that of the control rats, while at 
50.0 mg/kg, it was not significantly different from that of 
the UNFC (Figure 9). Among the INR, there was no 
significant difference between GPT levels in treated and 
INFC, except at 25.0 mg/kg where it was significantly 
lower. GPT activity was significantly higher in INR than in 
UNR at 50.0 mg/kg of artemether. The liver cells are also 
degenerating. Tissue necrosis was evident in the slide; 
the cell boundaries  are not well defined. The central 
vein (C) is still enlarged, but not completely well 
demarcated.  
 
 
DISCUSSION 
 
In the UNR that were treated with artemether, there was 
a slight but significant increase in the total and 
conjugated bilirubin levels in the plasma (Figures 1 and 
2); while significantly higher levels were observed in the 
INR. Scott et al. (1989) and Meshnick et al. (1991) 
reported that high concentrations of artemisinin caused 
oxidation of blood cell membrane proteins and decrease 
in red blood cell deformability; they suggested that the 
drug may affect the plasma membrane function in 
infected erythrocytes. Plasmodium causes rapid 
haemolysis or red blood cell break down, which results in 
increased plasma bilirubin level. When red blood cells are 
haemolyzed rapidly and the hepatic cells cannot excrete 
the bilirubin as rapidly as it is formed, there is an increase 
in the plasma level of bilirubin (Burtis and Ashwood, 
1996; Guyton, 2001). When there is obstruction of the 
bile ducts as it occurred in gallstone or  there  is  damage  
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Figure 8. Effect of artemether on the GOT activity in the plasma of uninfected and P. berghei infected rats. Each bar is mean ± 
S.E.M. (n = 20). *Significant difference between INR and UNR. 
b
Significant difference between control and INR. 
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Figure 9. Effect of artemether on the GPT activity in the plasma of uninfected and P. berghei infected rats. Each bar is mean 
+ S.E.M. (n = 20). *Significant difference between INR and UNR. 
a
Significant difference between control and UNR. 
b
Significant difference between control and INR. 
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Plate 1. Photomicrograph of the liver of UNR that received 
normal saline i.m. for 7 days. Mag x400. The cells appear normal. 
The sinusoidal spaces (S) are distinct. The nuclei of the cells (N) 
also appear normal. 
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Plate 2. Photomicrograph of the liver of UNR that received 12.5 
mg/kg of artemether i.m. for 7 days. Mag x400. The cells also 
appear normal except that their nuclei (N) are densely stained. 
The sinusoidal spaces (S) are also very distinct.  
 
 
 
to the liver cells, as in hepatitis, the rate of bilirubin 
formation is normal, but the bilirubin formed cannot pass 
from the blood into the intestines (Guyton, 2001; Ganong, 
2003). The free bilirubin usually still enters the liver cells 
and becomes conjugated. This conjugated bilirubin is 
then returned to the blood probably by rupture of the 
congested bile canaliculi and direct emptying of the bile 
into the lymph leaving the liver. Thus, most of the bilirubin 
in the plasma becomes the conjugated type rather than 
the free type (Guyton, 2001; Ganong, 2003). Plates 1 to 8 
show marked liver cell damage in both the infected and 
uninfected rats that were treated with artemether. The 
liver cell necrosis and the effect of high concentration of 
artemisinin on blood cell membrane were responsible for 
the increased level of bilirubin in the plasma of the 
treated rats in this study. This study therefore reveals that 
high doses of artemether were not only neurotoxic as 
reported by previous researchers, but also hepatotoxic. 
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The plasma level of cholesterol increased significantly 
at 50.0 mg/kg in the UNR, but that of the INR was 
significantly higher than the UNR at all the doses tested 
(Figure 3). Increased plasma level of cholesterol is one of 
the features of nephrotic syndrome and obstructive 
jaundice (Burtis and Ashwood, 1996; 2001; Dunn, 2003). 
We have reported the nephrotoxic effects of these doses 
of artemether in healthy and P. berghei infected rats in 
our previous studies (Akomolafe et al., 2011; 2012). The 
observed increase in the plasma concentrations of 
cholesterol in the present study revealed that the high 
doses of artemether tested induced liver damage in both 
infected and uninfected rats, a fact that was also 
corroborated by the photomicrographs of the liver tissue 
(Plate 1 to 8).  
There was a slight but significant reduction in the 
plasma glucose level of the UNR (Figure 4). That of the 
INR was lower than that of the UNR, except at 50.0 
mg/kg (Figure 4). A reduction in food consumption or 
prolonged starvation reduces the plasma glucose level 
(Guyton, 2001; Ganong, 2003). The pattern of anorexia 
induced by artemether in both categories of rats has 
been reported in one of our previous studies (Akomolafe 
et al., 2006). In that study, we reported that anorexia was 
more pronounced in the INR than in the UNR. The lower 
plasma glucose level of INR was due to greater 
artemether induced anorexia in the rats. In that same 
study, we reported an increased urination without a 
corresponding increase in water intake in INR that 
received 50 mg/kg of artemether, leading to severe 
dehydration. The dehydration which occurred in INR that 
got 50.0 mg/kg of artemether could be responsible for 
their higher plasma level of glucose despite a significant 
reduction in food intake. 
In the UNR, the plasma activity of GOT in the treated 
rats was not significantly different from that of the control 
rats (UNFC) (Figure 8). The activity of this enzyme in INR 
was significantly greater than in UNR at any particular 
dose of artemether, and even in the control. Wotton 
(1964) reported that the heart and the liver are 
particularly rich in GOT and that damage to these organs 
which involves necrosis of cells or increased cell 
permeability can be expected to raise activity of the 
enzyme. This study reveals extensive damage to the liver 
tissue caused by artemether. Plates 1 to 8, which was 
responsible for the increase in GOT activity observed in 
this study. The greater increase in the activity of GOT in 
the INR, was due to the inflammation of the liver cells 
induced by the malaria parasites. Protozoal infection 
(which includes malaria) evokes a form of inflammatory 
process in the body tissues and organs (Goodwin, 1976; 
Bowman and Rand, 1980). Acute inflammatory response 
in the host is usually triggered off by the injury of the body 
cells so that the normal intracellular constituents are 
released into the surroundings. The higher activity of 
GOT in the INR in this study is in conformity with the 
report of these workers. 
The plasma GPT activity of  the  UNR  increase  signifi- 
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Plate 3. Photomicrograph of the liver of UNR that received 25.0 mg/kg of artemether i.m. for 7 days. Mag x400. 
There is much cytoplasmic vacuolation (V) which is an evidence of inflammation. The sinusoidal spaces are 
obliterated. The central vein (C) is highly inflamed.  
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Plate 4. Photomicrograph of the liver of UNR that received 50.0 mg/kg of artemether i.m. for 7 days. Mag x400. 
There is marked cytoplasmic vacuolation (V). The cells are very big and plumpy as a result of advance stage of 
inflammation. The sinusoidal spaces are completely closed. The central vein (C) is also inflamed. 
Akomolafe et al.         1285 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V 
V 
 
 
Plate 5. Photomicrograph of the liver of INR that received normal saline i.m. for 7 days. Mag x400. The liver 
cells are vacuolated (V) and plumpy. The sinusoids are not visible because they have been closed by the 
inflamed cells. 
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Plate 6. Photomicrograph of the liver of INR that received 12.5 mg/kg of artemether i.m. for 7 days. Mag x400. 
The liver cells are also vacuolated (V). The sinusoids (S) are closed. The central vein (C) is very large. These 
are also evidences of inflammation. Cell degeneration is also evident in this tissue. 
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Plate 7. Photomicrograph of the liver of INR that received 25.0 mg/kg of artemether i.m. for 7 days. Mag x400. Some of 
the liver cells are either degenerating or have degenerated completely. The central vein (C) is enlarged as a result of 
inflammation. 
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Plate 8. Photomicrograph of the liver of INR that received 50.0 mg/kg of artemether i.m. for 7 days. Mag x400. 
 
 
 
 
cantly at 12.5 and 25.0 mg/kg only, while there was no 
significant increase in the level of the enzyme in the INR 
(Figure 9), despite the observed damage to the liver of 
these rats (Plate 1 to 8). GPT activity rises rapidly after 
myocardial infarction, peak values are reached within 24 
to 48 h, and normal levels are regained typically within 
three to five days. GPT activity is not usually elevated in 
myocardinal infarction unless the lesion is a large one, or 
there is associated liver damage (Wotton, 1964; Burtis et 
al., 1996). The observed reduction in the activity of GPT 
among the INR in this study, despite the liver damage 
could be due to the time lag between the onset of liver 
tissue damage and the assay of the enzyme. From the 
results of this study, it is concluded that high doses of 
artemether is toxic to the liver of both infected and 
uninfected rats, resulting in the impairment of liver 
functions which manifested as tissue necrosis, 
accumulation of metabolic wastes and elevation of the 
activity of liver enzymes in the blood.  
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